Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06586398 · ClinicalTrials.gov registry record · NA
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID
A NA study of Fatigue and Long COVID-19, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06586398: Active NA study of Fatigue and Long COVID-19, sponsored by University of California, Los Angeles.
NCT06586398 is a NA study of Fatigue and Long COVID-19 that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 10 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06586398, a NA study of Fatigue and Long COVID-19, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot randomized trial of rTMS for symptoms of fatigue and brain fog, and other neuropsychiatric symptoms of Long-COVID (Post-COVID, post-acute sequelae of COVID-19 infection, PASC). Twenty participants diagnosed with Long-COVID and recruited from the UCLA Long-COVID clinic will be randomized to receive active rTMS versus sham stimulation for 15 treatments followed by another 15 open-label rTMS treatments. Investigators will compare the safety and tolerability of rTMS vs Sham and examine within-group changes in symptoms of fatigue, sleep, pain, mood, and subjective and objective cognitive impairment. This project will provide information and pilot data for future larger clinical trials.
Primary Outcome
Safteesi is an instrument that assesses any new symptom(s) that participants developed since starting the clinical study.
Conditions Studied
Interventions
- DEVICE rTMS
Study Locations (1)
California
- UCLA Semel Institute - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2026-06-15 |
| Phase | NA |
What the registry record for NCT06586398 still lists
NCT06586398 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (95% lower).
The record links to 4 conditions, with Fatigue appearing as the primary indexed condition, and to 1 intervention - of which rTMS is the first listed.
NCT06586398 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06586398 about?
NCT06586398 is a clinical study titled "A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID". This is a pilot randomized trial of rTMS for symptoms of fatigue and brain fog, and other neuropsychiatric symptoms of Long-COVID (Post-COVID, post-acute sequelae of COVID-19 infection, PASC). Twenty participants diagnosed with Long-COVID and recruited from the UCLA Long-COVID clinic will be randomi...
What is the current status of trial NCT06586398?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-01-01. Estimated completion is 2026-06-15.
What conditions does trial NCT06586398 study?
This clinical trial studies the following conditions: Fatigue, Long COVID-19, Brain Fog, PASC Post Acute Sequelae of COVID 19.
What interventions are being tested in trial NCT06586398?
The interventions under investigation include: rTMS (DEVICE).
Who is sponsoring clinical trial NCT06586398?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06586398 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06586398's enrollment target sits among peer trials
10 103rd of 109 higher than 5 of 109 other Fatigue trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI